Drug Patent Expirations for the Week of February 21, 2021

CARDIZEM LA (diltiazem hydrochloride) Bausch Patent: 6,923,984 Expiration: Feb 25, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]
The post Dr…


New patent for Biocryst drug RAPIVAB

Annual Drug Patent Expirations for RAPIVAB Rapivab is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Biocryst drug RAPIVAB appeared first on DrugPat…


Biotechblog